A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3


Kuter D., Phil D., Gonzalez Lopez T. J., Trautmann-Grill K., FIEDLER M., Young-Ill Choi P., ...More

66th ASH Annual Meeting, san diego, United States Of America, 7 - 10 December 2024, vol.144, pp.710-711, (Full Text) identifier

  • Publication Type: Conference Paper / Full Text
  • Volume: 144
  • Doi Number: 10.1182/blood-2024-201418
  • City: san diego
  • Country: United States Of America
  • Page Numbers: pp.710-711
  • Kocaeli University Affiliated: Yes